Karolinska Development´s portfolio company OssDsign reports substantial progress in the process towards reimbursement of OSSDSIGN ...
(WorldNews Sweden)

STOCKHOLM, SWEDEN - 23 May 2019. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that its portfolio company OssDsign has experienced a substantial step forward in the process towards reimbursement of OSSDSIGN Cranial PSI in France. Hauté Autorité de Santé (HAS), the French health technology assessment institute, has given an initial positive opinion regarding use of OssDsigns unique product for cranioplasty to be covered by the French national reimbursement system. France is the only remaining European key market where OSSDSIGN Cranial PSI to date lacks reimbursement. ......